Welcome to the “Pathophysiology of the Placenta” Group, headed by Isabella Ellinger. This group is part of the Department of Pathophysiology and Allergy Research at the Center of  Pathophysiology, Infectiology and Immunology of the Medical University of Vienna in the Austrian capital, Vienna.

The primary aim of my research group is to study uptake/traffic/effects of maternal macromolecules at the materno-fetal interface under physiologic and pathophysiologic conditions.

The second important mission is science education and scientific communication /knowledge dissemination.

Click here for further informations

News!  News !  News!  News !  News!  News !  News!  News !

Publications                                                                                                 Projects                                                                                                   

Science education

Andrea Aharanwa awarded for report of Talente Praktikum 2015

Forschung hautnah Isabella Ellinger - Katharina Gelles

MedUni Wien/F. Matern

New applications for tried and tested medicines

(Vienna, 02-11-2015) The Medical University of Vienna is coordinating an international research project, which investigates the effectiveness of tried and tested medicines for the treatment of some of the heaviest burdens of our modern society including diseases such as cancer, diabetes and cardiovascular diseases. One molecule that these disorders have in common is a receptor known as the calcium-sensing receptor (CaSR), which is the molecular starting point of this project. Abnormal CaSR function can not only trigger familial benign hypercalcaemia and hyperparathyroidism but it is also involved in various other diseases such as Alzheimer's disease, diabetes, cancer and cardiovascular diseases. A four-year EU project is now investigating whether these medicines that modulate the function of CaSR, could be used for the treatment of the above-mentioned diseases.

"CaSR Biomedicine" project is the second European Training Network that Enikö Kallay has brought to the MedUni Vienna in the last five years. By coordinating this Marie Sklodowska-Curie Actions project, which is funded by 3.6-million-Euros of the Horizon 2020 programme of the EU, Enikö Kallay facilitates the cooperation of 13 research groups in eight countries – a network which will foster research excellence centred around the MedUni Vienna.  Sabina Baumgartner-Parzer of the Clinical Division of Endocrinology & Metabolism (Department of Internal Medicine III) and Isabella Ellinger (Institute of Pathophysiology and Allergy Research) will be assisting her in the implementation of the project.

MedUni Wien/F. Matern